Stock listing

BOATS:NXL Nexalin Technology, Inc. Stock

US listing (BOATS) of Nexalin Technology, Inc. · home listing NASDAQ:NXL

Follow Nexalin Technology, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:NXL

$2.36 USD +0.01 (+0.4%)

Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:NXL

Since Jul 6, 2026 +574.3% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits
Day range
$2.12 – $2.42 USDOct 19, 2026
Volume
57,597 sharesOct 19, 2026
Market value
$2.47M USDAt the close on Oct 19, 2026 · price × 1.05M shares outstanding
Nexalin Technology, Inc. logo
Ticker
BOATS:NXL
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
BOATS
Currency
USD

What changed lately

Latest news

Nexalin Technology Regains Compliance with Nasdaq Minimum Bid Price Requirement; Nasdaq Hearings Panel Grants Request for Continued Listing

Oct 8, 2026

Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in its Transition Toward Commercial Revenue Generation

Oct 1, 2026

Nexalin Technology Taps Neuromodulation Commercial Executive Robert DiTota to Advise on its Global Commercialization Strategy

Sep 29, 2026

Nexalin Technology Announces New Secondary Analysis of Previously Published Clinical Trial Data Reveals Previously Unreported Improvements in Memory, Comprehension and Language Function in Alzheimer’s Patients; ADAS-Cog Subscale Analysis to Guide Design of Planned U.S. Alzheimer’s Pilot Study

Sep 3, 2026

Nexalin Technology Announces Reverse Stock Split

Aug 27, 2026

Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s Proprietary DIFS™ Platform

Jun 23, 2026

Nexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across Depression, Insomnia and Quality of Life as Company Advances Brazilian Sales Plan.

Jun 10, 2026

Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia

Jun 4, 2026

Nexalin Technology Secures Key Neurostimulation Legislative Provision and Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research

May 22, 2026

Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of Veterans Affairs for Traumatic Brain Injury

May 21, 2026

All Nexalin Technology, Inc. news

Decks

Nexalin Technology, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
28 in the last 12 months · 96 in all · newest Oct 8, 2026 · oldest 2022
Decks
7 decks · latest March 2026

Where Nexalin Technology, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:NXL · Home listingNASDAQUnited StatesUSD
BOATS:NXL · This pageBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Nexalin Technology, Inc.